Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2026-01-02 @ 10:39 PM
Study NCT ID:
NCT00871169
Status:
COMPLETED
Last Update Posted:
2016-06-14
First Post:
2009-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Sponsor:
New Mexico Cancer Research Alliance
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
INST 0802
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None